Abstract
HIV-1-infected patients can have peripheral fat loss or lipoatrophy of the face, limbs, and buttocks and central fat accumulation within the abdomen, breast, and the dorso-cervical spine both of which may be present in the same individual. Lipoatrophy causes negative psychosocial impact and an impairment of quality of life because of erosion of self-image and self-esteem, demoralization and depression, problems in social and sexual relations, and threats to locus of control.
Surgical treatments for facial lipoatrophy include autologous fat transplant (AFT) from a subcutaneous abdominal graft or injections of biodegradable or nonbiodegradable fillers into the lipoatrophic areas of the face. The authors discuss how to choose from the different surgical procedures to treat HIV-related facial lipoatrophy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51–8.
Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. “Buffalo hump” in men with HIV-1 infection. Lancet. 1998;351(9106):867–70.
Stricker RB, Goldberg B. Fat accumulation and HIV-1 protease inhibitors. Lancet. 1998;352(9137):1392.
Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS. 1999;13(13):1659–67.
Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet. 1998;351(9106):871–5.
Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14(3):F25–32.
Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS. 2000;14(1):37–49.
Carr A, Law M. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr. 2003;33(5):571–6.
Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220–34.
James J, Carruthers A, Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg. 2002;28(11):979–86.
Fenske NA, Lober CW. Structural and functional changes of normal aging skin. J Am Acad Dermatol. 1986;15(4 Pt 1):571–85.
Gonzalez-Ulloa MSF, Flores E. The anatomy of the aging face. In: Hueston JT, editor. Transactions of the fifth international congress of plastic and reconstructive surgery. London: Butterworth; 1971. p. 1059–66.
Hall DA, Blackett AD, Zajac AR, Switala S, Airey CM. Changes in skinfold thickness with increasing age. Age Ageing. 1981;10(1):19–23.
Tan CY, Statham B, Marks R, Payne PA. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol. 1982;106(6):657–67.
Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read. 2000;10(9):546–50.
Guaraldi G, Orlando G, De Fazio D, De Lorenzi I, Rottino A, De Santis G, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005;10(6):753–9.
Negredo E, Higueras C, Adell X, Martinez JC, Martinez E, Puig J, et al. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDs. 2006;20(12):829–37.
Brown C, Schulberg HC. Diagnosis and treatment of depression in primary medical care practice: the application of research findings to clinical practice. J Clin Psychol. 1998; 54(3):303–14.
Orlando G, Guaraldi G, De Fazio D, Rottino A, Grisotti A, Blini M, et al. Long term psychometric outcomes of facial lipoatrophy therapy. AIDS Patient Care STDs. 2007; 21(11):833–42.
Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984; 40(6):1365–7.
Acknowledgement
We thank G. Orlando, M.D. and C. Stentarelli, M.D. for their assistance in the project.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Guaraldi, G., Bonucci, P.L., De Fazio, D. (2012). Comparison of Three Different Methods for Correction of HIV-Associated Facial Lipodystrophy. In: Erian, A., Shiffman, M. (eds) Advanced Surgical Facial Rejuvenation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17838-2_64
Download citation
DOI: https://doi.org/10.1007/978-3-642-17838-2_64
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17837-5
Online ISBN: 978-3-642-17838-2
eBook Packages: MedicineMedicine (R0)